These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2878588)

  • 1. Preparation and efficacy of antiherpes type 1 and 2 subunit vaccines.
    Kavaklova L; Dundarov S; Andonov P; Bakalov B; Dundarova D; Brodvarova I
    Acta Virol; 1986 Sep; 30(5):402-10. PubMed ID: 2878588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subviral herpes simplex vaccine.
    Kutinovà L; Slichtová V; Vonka V
    Dev Biol Stand; 1982; 52():313-9. PubMed ID: 6299840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatment of primary and recurrent HSV-2 infection in guinea pigs.
    Simms JR; Heath AW; Jennings R
    J Infect Dis; 2000 Apr; 181(4):1240-8. PubMed ID: 10762560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple novel procedure for preparation of herpes simplex virus subunit vaccine.
    Rajcáni J; Matis J; Kúdelová M; Lesko J; Reichel M; Fuchsberger N; Lesso J
    Acta Virol; 1988 Jul; 32(4):317-28. PubMed ID: 2903636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant interleukin 2 as an adjuvant for vaccine-induced protection. Immunization of guinea pigs with herpes simplex virus subunit vaccines.
    Weinberg A; Merigan TC
    J Immunol; 1988 Jan; 140(1):294-9. PubMed ID: 2826591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic properties of formalin herpes antigen prepared from cell cultures.
    Benda R; Dbalý V
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):237-49. PubMed ID: 4354219
    [No Abstract]   [Full Text] [Related]  

  • 7. Herpes simplex virus subunit vaccine: characterization of the virus strain used and testing of the vaccine.
    Hilfenhaus J; Moser H; Herrmann A; Mauler R
    Dev Biol Stand; 1982; 52():321-31. PubMed ID: 6299841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic periocular vaccination with a subunit vaccine induces higher levels of herpes simplex virus-specific tear secretory immunoglobulin A than systemic vaccination and provides protection against recurrent spontaneous ocular shedding of virus in latently infected rabbits.
    Nesburn AB; Burke RL; Ghiasi H; Slanina SM; Wechsler SL
    Virology; 1998 Dec; 252(1):200-9. PubMed ID: 9875329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine induced HSV 1 antibodies fail to correlate with protection against HSV 2 in guinea pigs.
    Welch MJ; Ridgeway PH; Phillpotts RJ
    FEMS Microbiol Immunol; 1988 Dec; 1(3):157-62. PubMed ID: 2856207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody and cell-mediated immunity to a DNA free herpes simplex subunit vaccine.
    Cappel R; de Cuyper F; de Braekeleer J
    Dev Biol Stand; 1979; 43():381-5. PubMed ID: 230114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restriction of latent herpes virus infection in rabbits immunized with subviral herpes simplex virus vaccine.
    Rajcáni J; Kutinová L; Vonka V
    Acta Virol; 1980 May; 24(3):183-93. PubMed ID: 6107035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
    J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of subviral herpes simplex virus preparations. I. Formation of neutralizing antibodies in different animal species after administration of herpes simplex virus solubilized antigens.
    Kutinová L; Slichtová V; Vonka V
    Arch Virol; 1979; 61(1-2):141-7. PubMed ID: 229789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and some properties of neutralizing antigens of herpes simplex virus.
    Kutinová L; Vonka V; Rezácová D
    Acta Virol; 1977 May; 21(3):189-97. PubMed ID: 18916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of experimental vaccines for bovine viral diarrhea in bovines, ovines and guinea pigs.
    Fernández F; Costantini V; Barrandeguy M; Parreño V; Schiappacassi G; Maliandi F; Leunda M; Odeón A
    Rev Argent Microbiol; 2009; 41(2):86-91. PubMed ID: 19623897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex vaccine using cell membrane associated antigen in an animal model.
    Thornton B; Griffiths JB; Walkland A
    Dev Biol Stand; 1981; 50():201-6. PubMed ID: 6281105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a herpes simplex virus subunit glycoprotein vaccine for prophylactic and therapeutic use.
    Burke RL
    Rev Infect Dis; 1991; 13 Suppl 11():S906-11. PubMed ID: 1664126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome encapsulated subunit (VP1) and virion vaccines against foot-and-mouth disease.
    Vasantha S; Antony A; Lal SM
    Acta Virol; 1987 Mar; 31(2):109-15. PubMed ID: 2886019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against herpes simplex virus in a group of healthy humans without reactions to herpes simplex virus antigens in blasttransformation assays.
    Møller-Larsen A
    J Clin Lab Immunol; 1986 Jul; 20(3):121-7. PubMed ID: 3018253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.